Harpswell Capital Advisors LLC Makes New Investment in SPDR S&P Biotech ETF $XBI

Harpswell Capital Advisors LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 16,768 shares of the exchange traded fund’s stock, valued at approximately $1,680,000. SPDR S&P Biotech ETF comprises approximately 1.6% of Harpswell Capital Advisors LLC’s investment portfolio, making the stock its 10th largest holding.

A number of other institutional investors have also recently bought and sold shares of the business. Prospera Financial Services Inc lifted its holdings in shares of SPDR S&P Biotech ETF by 103.2% during the third quarter. Prospera Financial Services Inc now owns 15,964 shares of the exchange traded fund’s stock worth $1,600,000 after buying an additional 8,109 shares in the last quarter. Continental Investors Services Inc. acquired a new position in SPDR S&P Biotech ETF during the third quarter worth about $252,000. Breakwater Capital Group grew its stake in shares of SPDR S&P Biotech ETF by 33.4% during the third quarter. Breakwater Capital Group now owns 14,887 shares of the exchange traded fund’s stock worth $1,492,000 after buying an additional 3,726 shares during the last quarter. Tempus Wealth Planning LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at about $233,000. Finally, Gruss & Co. LLC acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter worth $401,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $126.11 on Tuesday. The company has a market capitalization of $8.43 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $132.09. The business’s 50-day moving average is $124.24 and its 200-day moving average is $109.01.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.